www.criteriuminc.comAPRIL 2010

 This Month's Clinical Focus: FIBROMYALGIA

 Acupuncture found lacking for fibromyalgia
Fibromyalgia, a debilitating pain syndrome that affects an estimated 2 to 4 percent of the population, is characterized by chronic pain, fatigue and difficulty sleeping. It's a somewhat mysterious condition with no clear-cut cause.

Acupuncture may provide some temporary pain relief for people with fibromyalgia, but does not help with fatigue, sleep problems, or physical function, according to a new research review. However, the results are too inconsistent to recommend acupuncture as a treatment fibromyalgia, the reviewers conclude.

Winfried Hauser of the Klinikum Saarbrucken in Germany and colleagues reviewed seven randomized controlled trials of acupuncture that included a total of 385 people with fibromyalgia. The study subjects were mostly white middle-aged women.

All of the studies used traditional Chinese acupuncture, where fine needles are inserted into specific points in the skin. In addition, two of the studies used electroacupuncture, where the practitioner fits the needles with clips that are attached to a small device that delivers a continuous electrical impulse to stimulate the acupuncture point. Three of the studies used control groups with various kinds of sham or simulated acupuncture, and one compared simulated acupuncture to no treatment.

While the investigators found "strong evidence" that acupuncture relieves fibromyalgia pain, they caution that the results were too inconsistent to recommend it for the management of the condition.

They came to this conclusion mainly because, in one of the seven studies, sham and simulated acupuncture yielded better results than real acupuncture treatment. Furthermore, the authors found that acupuncture-related pain relief only occurred right after treatment, and did not last until the next follow-up.

"Choosing appropriate control conditions in clinical acupuncture trials on chronic pain syndromes is a particularly difficult problem," Hauser noted in an email to Reuters Health.

"Acupuncture is an effective treatment for several painful conditions, and most acupuncture therapists achieve good results for treatment. However, in most studies on acupuncture and pain, there is no difference between acupuncture and the control condition (often sham or minimal acupuncture)," the investigator added.

Despite this lack of strong evidence for acupuncture in treating fibromyalgia, the authors acknowledge that the treatment is still popular among patients.

They therefore recommend that further studies be undertaken, including larger, multi-center studies; studies involving comparisons with traditional medical treatments; and different forms and intensities of stimulation (i.e., manual vs. electric stimulation).
(
SOURCE: Rheumatology, January 25, 2010.)


 Immune treatment helps chronic pain patients
Treating the immune system can dramatically ease suffering

Treating the immune system can dramatically ease the suffering of people with chronic pain from an injured limb or following an amputation, a finding that could change the way such pain is treated, scientists reported.

Researchers from the University of Liverpool said a dose of a blood product called intravenous immunoglobin (IVIG) significantly reduced pain in almost half of patients with Complex Regional Pain Syndrome (CRPS) -- an unexplained chronic condition that can develop after injury to, or loss of, a limb.

"The discovery is expected to have a real impact on the treatment of other unexplained chronic pain conditions; if one pain condition can be effectively treated with an immune drug, then it is possible that other types will also respond," said Andreas Goebel, an expert in pain medicine who led the study.

IVIG is a human blood antibody used to treat immune disorders and some forms of leukemia. It balances immune systems, strengthening those that are weak and reducing activity in those that are overactive.

The researchers, whose study was published in the Annals of Internal Medicine journal, gave a single low-dose transfusion of IVIG to 13 volunteers with pain syndrome and found it significantly eased the pain in just under 50 percent of them.

The pain relief lasted five weeks on average and the treatment had few adverse side effects, they said. "The real effect of this treatment...may turn out to be even greater than what we have already seen," said Goebel.

He said that while the patients in the study were given a single, low-dose infusion of IVIG, the treatment could in future be given in higher doses, and repeated to give extra benefits.

The scientists said they were trying to develop ways to allow patients to administer IVIG treatment in their own homes. According to the researchers, complex regional pain syndrome -- also commonly called reflex sympathetic dystrophy -- can arise after any type of injury.

Some forms follow damage to a nerve, and in some cases the pain can be so severe that patients request amputation, only to find that the pain returns in the stump.
(by Kate Kelland, editing by Jon Boyle for Reuters Health)


 If you want to accelerate your clinical trials,
 you need to change the workflow paradigm.

Criterium knows resources are precious, time is the enemy, and results are paramount. Our user-friendly technologies are integrated into all aspects of our clinical development services for improved efficiencies. And a talented in-house staff that is committed to the professional support of our clients individual and particular needs is the backbone of our processes for maximum client outcomes.

 We have managed successful clinical trials for 
 over 19 years.

Of particular interest to you would be our experience with FIBROMYALGIA and PAIN TRIALS, including:  Pain Management (Narcotic, Non-narcotic, Acute and Chronic Pain, Post-operative Pain, Fibromyalgia, Wisdom Tooth Extraction, Low Back Pain, Osteoarthritis, Rheumatoid Arthritis, Malignant and Non-Malignant Pain, Cancer Pain, Headache Pain, Migraine, Transcutaneous Nerve Stimulation), CNS (Alzheimer's Disease, Anxiety, Depression, Multiple Sclerosis, Chronic Fatigue Syndrome, Schizophrenia, Bipolar Disease, Panic Disorder), Immunology, and Internal Medicine studies.

 We have several propriety technology solutions 
 that are proven to improve your clinical trial results.
Contact: John Hudak, President at
jmhudak@criteriuminc.com

WHAT'S NEW AT CRITERIUM:
 CRITERIUM, Inc. Global CRO Releases New Whitepaper
June 15, 2009

 
CRITERIUM, Inc. Global CRO Offers "A La Carte" Service Structure
April 15, 2009
   CRITERIUM, Inc. Global CRO Expands Services to Canada
February 2, 2009

WHITE PAPERS
   NEW!! Critical Clinical Research Factors in the Down Economy
By Lawrence Reiter, Ph.D.
   The Evolution of the Data Management Role: The Clinical Data Liaison
By Mary Stefanzick
   India: A Target-Rich Environment
By Ronny Schnel

VIDEOS
   NEW!!  The DIA 2009 Interview
Featuring Lawrence Reiter, Ph.D.

 
Addressing the Challenge of Finding Investigators for Clinical Trials
Featuring Kabelo Pududu
   The Clinical Data Liaison: The Key to Better, Faster Clinical Trials
Featuring John M. Hudak

PODCASTS
 

 NEW!!  Science is Greater than the Economy   
Featuring Lawrence Reiter, Ph.D.

 The Clinical Data Liaison: The Key to Better, Faster Clinical Trials
Featuring John M. Hudak

   Agile Clinical Trials and the Use of Real-Time Data
Featuring John M. Hudak

PUBLICATIONS
 

 NEW!! Predictions for the 2010 Pharma Market
- Lawrence Reiter, Ph.D.

Journal for Clinical Studies


 NEW!! Maintaining Clinical Operations: It's Just Good Business 
- Lawrence Reiter, Ph.D.

PharmaVoice View on Clinical Operations

   EDC Implementation 
- Greg Bailey

PharmaVOICE, View on
E-Solutions
   Going Global 
- John M. Hudak

Future Pharmaceuticals
   Trials Limber Up 
- John M. Hudak

International Clinical Trials Magazine

PRESENTATION
   Criterium Capabilities Presentation

OUR BROCHURE
 

 Criterium -
Connect - Communicate - Control


 LINKS FOR YOUR INFO
 

 National FIBROMYALGIA AWARENESS DAY is MAY 12th

About Criterium Inc.  Criterium Inc. www.criteriuminc.com is a global, full-service, technology-driven contract research organization that offers a unique mix of high-quality, innovative clinical research solutions for the biopharmaceutical, pharmaceutical, medical device, and CRO industries.  

 CALL US FOR COMPETITIVE BIDS ON YOUR NEXT PROJECT:   
FULL-SERVICE RESEARCH - TRIAL RESCUE SERVICES - PRO
JECT & DATA MANAGEMENT - BIOSTATISTICS - SITE SELECTION & MANAGEMENT - PROTOCOL DESIGN & CONSULTING - CLINICAL & MEDICAL MONITORING - CRF DESIGN   IVR / IWR - FAX & ELECTRONIC DATA CAPTURE - MEDICAL WRITING - SAFETY - REGULATORY CONSULTING -- MORE!

GET TO KNOW US!
This email was sent by Criterium Inc.com. You are receiving this email because of your affiliation with Criterium Inc. If you do not wish to receive Criterium Inc. announcements and updates, please unsubscribe here. If the link is not working, please send an e-mail to releases@criteriuminc.com and type "UNSUBSCRIBE" in the subject line or please send a letter including your name, request for removal, and e-mail address to: Criterium Inc., 358 Broadway, Suite 201, Saratoga Springs, NY 12866.